The 2017 Lewis Rudin Glaucoma Prize was awarded to Mary Kelley, PhD, research associate professor of ophthalmology at Oregon Health & Sciences University, for her research paper, “Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma.”
Kelley is being recognized for her work in demonstrating that stem-like cells can be reintroduced into eyes with glaucoma, which corrects the underlying cause of the disease rather than just managing the complications. “There has never been a glaucoma treatment that corrected/repaired the cause and the potential for the future is exciting,” said selection committee chair David H. Abramson, MD, FACS, professor of ophthalmology at Weill-Cornell Medical School and chief of the Ophthalmic Oncology Service at Memorial Sloan-Kettering Cancer Center.
The Rudin Glaucoma Prize recognizes the most significant scholarly article on glaucoma published in a peer-reviewed journal in the prior calendar year. Recipients are nominated by their peers, and a winner is chosen by The New York Academy of Medicine’s Lewis Rudin Prize Selection Committee and approved by the Academy Board of Trustees.
Kelley, an active member of ARVO since 1999, has served on several committees including the Diversity Initiative Committee and WEAVR (Women in Eye and Vision Research) Networking Committee and as a mentor in the Developing Country Eye Research Fellowship.